Letrozole Breast Cancer Medication CAS:112809-51-5
Letrozole, a widely recognized and potent aromatase inhibitor (AI), has been a revolutionary drug in medical and fitness fields. This guide aims to provide an in-depth understanding of Letrozole, focusing on its features, applications, benefits, dosage guidelines, cycles, half-life, and the necessity of post-cycle therapy (PCT). Crafted with originality and attention to detail, this content ensures uniqueness while addressing critical aspects of this compound.
What is Letrozole?
Letrozole, marketed under the trade name Femara, is a non-steroidal AI primarily used to treat hormone-responsive breast cancer in postmenopausal women. Its ability to reduce estrogen production has extended its applications to the fitness community, where it serves as a crucial agent for managing estrogen-related side effects during anabolic steroid cycles.
Chemical Composition
●Chemical Name: 4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile
●Molecular Formula: C17H11N5
●Molecular Weight: 285.31 g/mol
●Appearance: White to off-white crystalline powder
●Mechanism: Inhibits the aromatase enzyme, preventing the conversion of androgens into estrogen.
Letrozole's potent action makes it a preferred choice for combating high estrogen levels, ensuring optimal hormonal balance in medical and fitness contexts.
Features of Letrozole
1.High Aromatase Inhibition Potency
●Letrozole can reduce estrogen levels by up to 98%, making it one of the most effective AIs available.
2.Selective Action
●Specifically targets the aromatase enzyme without affecting other hormonal pathways, reducing the risk of unintended side effects.
3.Long Half-Life
●Its extended duration of action allows for less frequent dosing, enhancing user convenience.
4.Minimal Systemic Impact
●Unlike some AIs, Letrozole does not directly suppress androgen production, making it a strategic choice for anabolic steroid users.
5.Multi-Context Application
●Used in both therapeutic and performance-enhancement settings due to its versatility and effectiveness.
Applications of Letrozole
Medical Applications
1.Breast Cancer Treatment
●Primarily prescribed for hormone receptor-positive breast cancer in postmenopausal women, reducing estrogen stimulation to cancerous cells.
2.Fertility Management
●Occasionally used off-label to stimulate ovulation in women with polycystic ovary syndrome (PCOS) or unexplained infertility.
3.Endometriosis
●Effective in managing estrogen-dependent conditions like endometriosis by lowering estrogen levels.
Performance and Fitness Applications
1.Estrogen Control During Steroid Cycles
●Essential for managing estrogenic side effects like gynecomastia, water retention, and fat gain associated with anabolic steroid use.
2.Post-Cycle Therapy (PCT)
●Helps restore hormonal balance by preventing estrogen rebound after a steroid cycle.
3.Enhancing Muscle Definition
●Reducing water retention ensures a dry, vascular, and defined appearance, ideal for bodybuilding competitions.
4.Improving Testosterone-to-Estrogen Ratio
●Elevated testosterone levels can lead to better strength, recovery, and overall performance.
Research Applications
In clinical research, Letrozole is studied for its effects on hormone-sensitive tissues, metabolic pathways, and potential applications in various endocrine disorders.
Benefits of Letrozole
1.Effective Estrogen Suppression
●Significantly lowers circulating estrogen levels, addressing symptoms of hormonal imbalances efficiently.
2.Prevention of Gynecomastia
●Prevents the development of male breast tissue, a common side effect of anabolic steroid use.
3.Enhanced Physical Aesthetics
●By eliminating excess water retention, users achieve a leaner and more sculpted physique.
4.Support for Testosterone Optimization
●Reduces estrogen feedback inhibition on the hypothalamus-pituitary-gonadal axis, potentially increasing natural testosterone production.
5.Improved Fertility Outcomes
●In women, Letrozole can stimulate ovulation and improve chances of conception when used under medical supervision.
Dosage Guidelines for Letrozole
Medical Dosage
●Breast Cancer Treatment: 2.5 mg daily as a standard dose.
●Fertility Enhancement: 2.5–5 mg daily for five days, starting on the third day of the menstrual cycle.
Performance Enhancement Dosage
●Estrogen Management: 0.5–1.25 mg every other day, adjusted based on individual response and estrogen levels.
●Severe Estrogenic Side Effects: Up to 2.5 mg daily for a short period, followed by a gradual taper to avoid over-suppression.
Administration Tips
●Take Letrozole with or without food for consistent absorption.
●Monitor estrogen levels through regular blood tests to adjust dosages appropriately.
Cycle Protocols with Letrozole
Standalone Cycle
●Duration: 4–6 weeks
●Dosage: 0.5 mg every other day
●Purpose: To lower elevated estrogen levels in individuals not using anabolic steroids.
Steroid Cycle Integration
●Cycle Length: Matches the duration of the anabolic steroid cycle.
●Dosage: 0.5–1.25 mg every other day, adjusted based on the aromatization potential of the steroids used.
Post-Cycle Therapy (PCT)
●Duration: 2–4 weeks
●Dosage: 0.25–0.5 mg daily to manage estrogen rebound and support hormonal recovery.
Half-Life and Pharmacokinetics
●Half-Life: Approximately 42 hours, allowing for once-daily or every-other-day dosing.
●Peak Plasma Levels: Reached within 2–4 hours of oral administration.
●Metabolism: Primarily in the liver, with inactive metabolites excreted via urine.
Post-Cycle Therapy (PCT) Role
Why is PCT Necessary?
Following anabolic steroid cycles, natural testosterone production is often suppressed. Letrozole aids in preventing estrogen rebound, which can exacerbate post-cycle symptoms.
Recommended PCT Protocol
1.HCG (Human Chorionic Gonadotropin): To stimulate testicular function.
●Dosage: 500–1,000 IU every other day for 2 weeks.
2.Selective Estrogen Receptor Modulators (SERMs): Such as Clomid or Nolvadex, to restore the hypothalamus-pituitary-gonadal axis.
●Clomid: 50 mg daily for 4 weeks.
●Nolvadex: 20 mg daily for 4 weeks.
3.Letrozole: 0.25–0.5 mg daily for 2 weeks, gradually tapering off to avoid over-suppression.
Side Effects and Risks
1.Over-Suppression of Estrogen
●Symptoms: Joint pain, mood swings, and reduced libido due to excessively low estrogen levels.
2.Bone Health Concerns
●Chronic estrogen suppression can lead to decreased bone mineral density, increasing fracture risk.
3.Liver Strain
●Though minimal, liver monitoring is recommended during long-term use.
4.Other Adverse Effects
●Fatigue, headaches, and gastrointestinal discomfort may occur, particularly at higher doses.
Storage and Handling of Letrozole
●Store in a cool, dry place at temperatures below 25°C.
●Protect from light and moisture to maintain potency.
●Use gloves and safety equipment when handling raw powder to avoid accidental contact or inhalation.
Clinical data
|
Product Name |
Femara |
|
CAS |
112809-51-5 |
|
Molar mass |
285.310 |
|
Formula |
C17H11N5 |
|
Purity |
Above 98% |
|
Apprarance |
White crystalline powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885
Conclusion
Letrozole is a powerful and versatile compound with applications ranging from breast cancer treatment to estrogen control during anabolic steroid cycles. Its ability to suppress estrogen effectively makes it a cornerstone drug in both medical and performance-enhancing contexts. However, its potent effects necessitate responsible use, proper dosage management, and close monitoring to avoid adverse effects. Whether used for therapeutic purposes or integrated into a fitness regimen, Letrozole remains a crucial tool for maintaining hormonal balance and optimizing results.
Hot Tags: letrozole breast cancer medication cas:112809-51-5, China letrozole breast cancer medication cas:112809-51-5 manufacturers, suppliers, factory, Anabolic androgenic steroids AAS Trenbolone Enanthate, Exemestane, Oxandrolone, Steroid Raw Powders Injectables, Testosterone, Trenbolone Acetate
